Lenalidomide as a Beneficial Treatment Option for Renal Impairment Caused by Light Chain Deposition Disease.
Kimura S, Ohkawara H, Ogawa K, Tanaka M, Sano T, Harada-Shirado K, Takahashi H, Ueda K, Shichishima-Nakamura A, Matsumoto H, Ikeda K, Kazama JJ, Hashimoto Y, Ikezoe T.
Kimura S, et al. Among authors: ikezoe t.
Intern Med. 2018 Dec 15;57(24):3651-3657. doi: 10.2169/internalmedicine.1018-18. Epub 2018 Aug 10.
Intern Med. 2018.
PMID: 30101913
Free PMC article.